Breaking News

Allergan Names CFO

August 18, 2014

Hindman succeeds Edwards

Jim Hindman has been named executive vice president of finance and business development, and chief financial officer at Allergan, Inc. Mr. Hindman succeeds Jeff Edwards, who after 21 years has decided to step down from the position, but will serve as a non-executive officer to facilitate the transition.
 
Mr. Hindman joined the company in 1984 and has served as senior vice president, Treasury, Risk and Investor Relations since 2002. Prior to that, he served in a variety of finance positions, including senior vice president, finance and controller, assistant corporate controller and vice president, Financial Planning and Analysis. Mr. Hindman also serves as president of The Allergan Foundation.  
 
“For more than two decades, Jeff Edwards has fully committed his considerable talents to serving Allergan and we have been exceptionally privileged to have him as a colleague,” said David E.I. Pyott, Allergan’s chairman and chief executive officer.
 
Mr. Pyott added, “We are pleased to name Jim Hindman as Allergan’s chief financial officer. Jim has been an instrumental member of our organization for many years, and particularly during the past few months, has played an important leadership role. We believe that Jim is ideally suited to assume the position of chief financial officer and we are confident that his long tenure and experience in our finance organization, together with his strong record as a leader in the Company, will be invaluable as he assumes his new role.”
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks